COMMUNIQUÉS West-GlobeNewswire

-
BeautyHealth to Report Third Quarter 2025 Financial Results on November 6, 2025
23/10/2025 -
IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting
23/10/2025 -
PCI Biotech update
23/10/2025 -
Abalos Therapeutics Doses First Patient in Phase 1 Study Evaluating ABX-001 for the Treatment of Solid Tumors
23/10/2025 -
Hydreight Reports Corporate Update and Ranks #25 on Deloitte’s 2025 Technology Fast 50™
23/10/2025 -
Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke
23/10/2025 -
'The World’s Greatest Health Van' Travels to Ottawa: 150,000 Canadians Call for The Charter of Health Freedom
23/10/2025 -
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
23/10/2025 -
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal Imaging
23/10/2025 -
Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers
23/10/2025 -
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
23/10/2025 -
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025
23/10/2025 -
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
23/10/2025 -
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
23/10/2025 -
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025
23/10/2025 -
Amphista Therapeutics announces three key strategic leadership appointments to drive transition of its Targeted Glue™ protein degraders into clinical development
23/10/2025 -
TRIDENT, a dedicated stroke outcomes trial in patients with a history of intracerebral hemorrhage (ICH), demonstrates the potential advantages of intensive blood pressure treatment with low-dose triple combination therapyTRIDENT, a dedicate
23/10/2025 -
EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025
23/10/2025 -
BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
23/10/2025
Pages